QC
QTTB icon

Quadrature Capital’s Q32 Bio QTTB Stock Holding History

Quadrature Capital’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$464K Buy
+36,396
New +$304K ﹤0.01% 1030

Other funds holding QTTB

S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.72% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Quadrature Capital's QTTB Position: Q2 2026 in Review

Quadrature Capital opened a new position in Q32 Bio (QTTB) in Q2 2026: 36,396 shares worth $464K. The stake represents ﹤0.01% of the portfolio and ranks #1030 among its holdings.

15 funds tracked by Wall St. Rank hold QTTB as of Q2 2026.

  • Quadrature Capital held 36,396 shares of Q32 Bio worth $464K as of Q2 2026.
  • Q32 Bio was a new Quadrature Capital position in Q2 2026.
  • Q32 Bio made up ﹤0.01% of Quadrature Capital's portfolio in Q2 2026, its #1030 holding.
  • 15 funds tracked by Wall St. Rank held Q32 Bio as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.